在COVID-19大流行之前和期间的非故意儿科中毒:基于人口的研究
Daniel T Myran1, Adrienne Gaudreault2, Stephen D S McCarthy2
1Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada; ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Bruyère Research Institute, Ottawa, Ontario, Canada.
The American journal of emergency medicine
|December 12, 2023
概括
随着COVID-19大流行,儿童中毒紧急诊所的总体数量有所下降,但住院病例的数量增加. 大麻中毒在儿童中显著增加,可能是由于合法化.
科学领域:
- 儿科毒理学 儿科毒理学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- COVID-19大流行对儿科无意中毒的影响仍未得到充分研究.
- 了解这些趋势对于公共卫生干预至关重要.
- 加拿大大麻合法化之前的流行病,提供了一个独特的比较点.
研究的目的:
- 分析COVID-19大流行对急诊室 (ED) 访问和因非故意儿科中毒住院的影响.
- 为了比较与大麻有关的中毒和儿童中非大麻中毒的趋势.
- 评估大麻和大麻食用合法化对儿科中毒事件的影响.
主要方法:
- 利用来自加拿大安大略省的人口数据的中断时间序列 (ITS) 分析.
- 在大流行前 (2020年1月至2020年3月) 和大流行期间 (2020年4月至2021年12月) 检查的儿科中毒 (年龄0-9岁).
- 对大麻和非大麻中毒的ED访问和住院情况进行比较.
主要成果:
- 总体而言,在疫情期间,儿科中毒ED访问减少了14.6%,而住院病例增加了35.9%.
- 大麻中毒事件显著增加:急救诊所增加了10.7倍,住院病例增加了12.1倍.
- 除大麻外,在大流行期间,儿童中毒住院病例总体没有显著增加.
结论:
- COVID-19大流行并没有与大多数非故意的儿科中毒事件的增加有关,除了涉及大麻的儿童中毒事件.
- 儿童大麻中毒的激增与加拿大的非医用大麻食用品合法化有关.
- 公共卫生策略可能需要解决儿童大麻暴露的日益增长的风险.
相关概念视频
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Steps in Outbreak Investigation
131
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
131
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
293
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
293


